Latest period
$0.00
YoY change
—
5Y CAGR
—
Peak year (2019)
$0.00
Latest annual
$0.00
Dividends Paid history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: $0.00
Dividends Paid history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | $0.00 | — | $0.00 | ||
| 2024 | $0.00 | — | $0.00 | ||
| 2023 | $0.00 | — | $0.00 | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | — | $0.00 | ||
| 2019 | $0.00 | — | — |
- 2025$0.00—
- 2024$0.00—
- 2023$0.00—
- 2022$0.00—
- 2021$0.00—
- 2020$0.00—
- 2019$0.00—
Dividends Paid values are taken from Climb Bio's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Dividends Paid at Climb Bio (CLYM)
Dividends Paid for Climb Bio (CLYM): headline value $0.00. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Climb Bio (CLYM) dividends paid is $0.00.
Climb Bio Dividends Paid by Year
Climb Bio Dividends Paid 2025: $0.00
Climb Bio dividends paid in 2025 was $0.00.
Climb Bio Dividends Paid 2024: $0.00
Climb Bio dividends paid in 2024 was $0.00.
Climb Bio Dividends Paid 2023: $0.00
Climb Bio dividends paid in 2023 was $0.00.
Climb Bio Dividends Paid 2022: $0.00
Climb Bio dividends paid in 2022 was $0.00.
Climb Bio Dividends Paid 2021: $0.00
Climb Bio dividends paid in 2021 was $0.00.
See more financial history for Climb Bio (CLYM).
Sector peers by Dividends Paid
Healthcare peers of Climb Bio (CLYM), ranked by their latest dividends paid
| $12.38B | |
| $11.66B | |
| $8.18B | |
| $8.07B | |
| $7.92B | |
| $5.38B | |
| $5.12B | |
| $5.08B |
- $12.38B
- $11.66B
- $8.18B
- $8.07B
- $7.92B
- $5.38B
- $5.12B
- $5.08B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation